Department of Paediatrics, KK Women's and Children's Hospital, Singapore, Singapore.
Department of Neonatal & Developmental Medicine, Singapore General Hospital, Singapore, Singapore.
PLoS One. 2019 Sep 12;14(9):e0222018. doi: 10.1371/journal.pone.0222018. eCollection 2019.
The association between hypothyroxinemia of prematurity with neurodevelopment was controversial.
To compare 5 year neurodevelopmental outcomes of very low birth weight (VLBW) infants with hypothyroxinemia of prematurity against those without.
Retrospective cohort study in a single tertiary neonatal centre of VLBW infants born between the year 2008 to 2011. Comparisons were made between all abnormal and normal thyroid function controls using cord thyroid function tests, thyroid function tests during admission and pre-discharge thyroid function test done at term equivalent age. At 2 years corrected age, Bayley scales of infant and toddler development-third edition and Vineland II adaptive behaviour scales (VABS) were collected. At 5 years, Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III), Bracken School Readiness Assessment, VABS and Beery Test of Visual-Motor Integration were collected.
110 subjects were studied at 2 years corrected age and 80 subjects at 5 years old. 29 infants had abnormal thyroid function test (10 infants with hypothyroxinemia of prematurity and 19 infants with transient thyroid abnormalities). There were no significant difference in the 2 years and 5 years developmental outcome between infants with and without hypothyroxinemia of prematurity (p-value>0.05); and between infants with and without transient thyroid abnormalities (p-value>0.05). There were no significant difference in neurological, visual and hearing impairment between infants with or without hypothyroxinemia of prematurity (p-value>0.05).
Hypothyroxinemia of prematurity or transient thyroid abnormalities in VLBW infants were not associated with poorer neurodevelopment and did not support the need for levothyroxine supplementation.
早产儿甲状腺功能减退与神经发育之间的关系存在争议。
比较伴有早产儿甲状腺功能减退症的极低出生体重儿(VLBW)与无甲状腺功能减退症的 VLBW 婴儿的 5 年神经发育结局。
对 2008 年至 2011 年间在一家单中心三级新生儿中心出生的 VLBW 婴儿进行回顾性队列研究。使用脐带甲状腺功能试验、入院期间甲状腺功能试验和足月等效龄前的预出院甲状腺功能试验,对所有异常和正常甲状腺功能对照组进行比较。在 2 岁时进行贝利婴幼儿发育量表第三版(Bayley scales of infant and toddler development-third edition)和文兰适应行为量表第二版(Vineland II Adaptive Behaviour Scales)评估,在 5 岁时进行韦氏学前和小学智力量表第三版(Wechsler Preschool and Primary Scale of Intelligence-III)、布雷肯学校准备评估、文兰适应行为量表和比瑞测验(Beery Test of Visual-Motor Integration)评估。
在 2 岁时对 110 名婴儿进行了研究,在 5 岁时对 80 名婴儿进行了研究。29 名婴儿甲状腺功能检查异常(10 名婴儿有早产儿甲状腺功能减退症,19 名婴儿有短暂性甲状腺异常)。伴有和不伴有早产儿甲状腺功能减退症的婴儿在 2 岁和 5 岁时的发育结果之间无显著差异(p 值>0.05);伴有和不伴有短暂性甲状腺异常的婴儿之间无显著差异(p 值>0.05)。伴有或不伴有早产儿甲状腺功能减退症的婴儿在神经、视觉和听觉障碍方面无显著差异(p 值>0.05)。
VLBW 婴儿的早产儿甲状腺功能减退症或短暂性甲状腺异常与较差的神经发育无关,也不支持补充左甲状腺素的必要性。